GlucoseTech | Continuous Glucose Monitoring (CGM) Education for Healthcare Providers

Pregnant Patients are Empowered by Real-Time Continuous Glucose Monitoring (CGM): How Biosensor Technology Supports Type 1 Diabetes, Type 2 Diabetes, Prediabetes, and Gestational Diabetes

How does real-time data from Continuous Glucose Monitoring (CGM) reshape how we talk about food, exercise, and metabolic health Exploring how CGM - and tools like Dexcom and Stelo are empowering people with type 1 diabetes, type 2 diabetes, and even prediabetes to better understand their glucose patterns and take charge of their diabetes management is host Cher Pastore, MS, RD, CDCES, BC-ADM, joined by Rachel Stahl Salzman, a registered dietitian and certified diabetes education specialist at Weill Cornell. 

Rachel shares practical insights from her work in diabetes treatment, including with pregnant patients managing gestational diabetes. She also discusses her recent study presented at Advanced Technologies & Treatments for Diabetes (ATTD), where CGM use helped women with gestational diabetes feel more confident and in control of their care. 

From glucose tracking to blood sugar monitoring, this episode explores how biosensor technology supports more personalized, effective diabetes management - not just for patients, but for endocrinologists and primary care providers too.

Whether you’re focused on diabetes treatment, nutrition, or simply curious about the future of diabetes technology, this episode of Real-Time Real Talk reveals how CGM is making care more precise, proactive, and powerful.

Brought to you by Dexcom https://provider.dexcom.com/education-research/podcast

How can Continuous Glucose Monitoring (CGM) help people with type 2 diabetes feel more empowered and in control of their health? Exploring compelling new research presented at the Advanced Technologies & Treatments for Diabetes (ATTD) conference is host Cher Pastore, MS, RD, CDCES, BC-ADM, and guest Sim Singh, Senior Director of Behavioral and Translational Science at Dexcom.

Together, they unpack findings from a 30-day study of Dexcom G7 use in people with type 2 diabetes, including those not on insulin. The results show significant improvements in glucose tracking, behavioral shifts like better nutrition and increased physical activity, and enhanced metabolic health and confidence - especially among CGM-naive users. Sim also shares insights from a Canadian trial and discusses how CGM is transforming diabetes education, not only for patients but for endocrinologists and primary care providers as well.

Whether it’s supporting blood sugar monitoring, enabling personalized diabetes treatment, or simply helping people better understand their glucose patterns, this conversation highlights how CGM and biosensor technology are reshaping diabetes management - for people with type 1 diabetes, type 2 diabetes, and even prediabetes.

Integrating glucose sensor Dexcom G7 with digital health apps like Happy Bob and Undermyfork is improving diabetes treatment decisions and patient engagement. Whether it’s gamifying glucose tracking, uncovering personalized glucose patterns, or making real-time adjustments, these digital tools empower both patients and providers.

Cher Pastore, MS, RD, CDCES, BC-ADM is joined by diabetes experts Jami Klein, BSN, RN, CDCES and Rachael Sood, RN, MSN, APRN, NP-C, CDCE to explore how apps like Happy Bob and Undermyfork integrate with Continuous Glucose Monitoring (CGM) to make tracking blood sugar levels more interactive and insightful.

Rachael shares real-world experiences from her diabetes care clinic, demonstrating how CGM-driven insights help patients with Type 1 diabetes, Type 2 diabetes, and prediabetes make better-informed treatment decisions. Jami brings her personal perspective on using CGM and apps to optimize diabetes management, highlighting the role of glucose sensors, blood sugar monitoring, and biosensor technology in simplifying daily care.

Together, they explore how diabetes technology is reshaping diabetes education, treatment, and metabolic health, and how digital health solutions are making a lasting impact in endocrinology and primary care.

Brought to you by Dexcom https://www.dexcom.com/

Welcome back to another episode of Real-Time Real Talk where this week, host Cher Pastore is joined by Dr Thomas Grace and Dr. William Polonsky to discuss the power of Continuous Glucose Monitoring (CGM) in managing type 2 diabetes.

Continuous Glucose Monitoring has revolutionized the management of diabetes. At its core, diabetes management is about balancing blood glucose levels to avoid the serious complications associated with hyperglycaemia and hypoglycaemia. CGM technology provides both patients and healthcare professionals with real-time data on glucose levels, making it a powerful tool in this balancing act.

In this episode Dr Grace and Dr Polonsky share their insights from their research, highlighting significant reductions in A1C levels and improvements in patient outcomes with the use of CGM. They highlight the clinical benefits of CGM for managing glucose levels and making informed dietary and lifestyle choices. Additionally, they discuss the psychological effects of CGM including increased engagement, empowerment, and reduced anxiety. 

Dr Grace also introduces an exciting new product from Dexcom called Stelo, which will be an over the counter option for patients with type two diabetes (not on insulin), meaning that if your doctor is unwilling to write you a prescription for a Dexcom G7, you yourself can go to www.stelo.com and see if an over the counter product is appropriate for you. 

Welcome back to another episode of Real-Time Real Talk. This week, host Cher Pastore is joined by Emily Cornelius, a Registered Dietitian, to discuss the science behind monitoring glucose levels in individuals with prediabetes and type 2 diabetes who are not on insulin as well as introducing a brand new product by Dexcom called Stelo. 

Having faced challenges with dieting as a young adult, Emily discovered the importance of nutrition. This experience set her on a career path and a personal mission to help more women love the way they look, eat, and feel. Through her work, she focuses on helping exhausted dieters achieve their goals by addressing the root cause of weight gain (insulin resistance) while still enjoying the foods they love. She is also well-known across social media platforms, where she highlights creative ways to eat healthily without letting diet consume all their time.

In this episode, Emily shares her experience using continuous glucose monitoring (CGM) and how it has helped her clients with insulin resistance and weight loss. They discuss the impact of glucose sensors on behavior change, the importance of personalized nutrition plans, and the accessibility of glucose sensors without a prescription. They also highlight the benefits of using glucose sensors in managing prediabetes and making informed food and exercise choices.

Emily and Cher also look at the brand-new product from Dexcom, Stelo, a glucose biosensor indicated for people with type 2 diabetes or prediabetes. Stelo tracks glucose 24/7, revealing how food, exercise, and even sleep can affect glucose levels, helping you become a healthier you.

Visit www.stelo.com to find out more.